Literature DB >> 3295858

The use and abuse of subgroup analysis in epidemiological research.

R A Stallones.   

Abstract

Most epidemiology involves the analysis of subgroups. In observational studies, identification of associations within particular subgroups is the usual method of investigation, while in experimental studies the purpose is to compare the rate of occurrence of the outcome of interest in treated and control groups. Problems can arise through failure to specify the subgroups of interest a priori and through examining large numbers of subgroups after the fact, i.e., through multiple testing. Rules for interpretation of findings in subgroups are suggested, and the value of the systematic application of criteria for judgement of the causal significance of any associations that may be observed is noted.

Mesh:

Year:  1987        PMID: 3295858     DOI: 10.1016/0091-7435(87)90082-x

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  12 in total

1.  Oral contraceptive formulation and risk of breast cancer.

Authors:  Polly A Marchbanks; Kathryn M Curtis; Michele G Mandel; Hoyt G Wilson; Gary Jeng; Suzanne G Folger; Jill A McDonald; Janet R Daling; Leslie Bernstein; Kathleen E Malone; Phyllis A Wingo; Michael S Simon; Sandra A Norman; Brian L Strom; Giske Ursin; Linda K Weiss; Ronald T Burkman; Robert Spirtas
Journal:  Contraception       Date:  2011-09-28       Impact factor: 3.375

2.  Ernst Wynder: a remembrance.

Authors:  Steven D Stellman
Journal:  Prev Med       Date:  2006-09-25       Impact factor: 4.018

Review 3.  Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects.

Authors:  David M Kent; Ewout Steyerberg; David van Klaveren
Journal:  BMJ       Date:  2018-12-10

4.  Assessing Heterogeneity of Treatment Effects: Are Authors Misinterpreting Their Results?

Authors:  Erik Fernandez Y Garcia; Hien Nguyen; Naihua Duan; Nicole B Gabler; Richard L Kravitz
Journal:  Health Serv Res       Date:  2010-02       Impact factor: 3.402

5.  Maternal hyperthermia during pregnancy and cardiovascular malformations in the offspring.

Authors:  J Tikkanen; O P Heinonen
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

6.  Brain disorders associated with corticotropin-releasing hormone expression in the placenta among children born before the 28th week of gestation.

Authors:  Alan Leviton; Elizabeth N Allred; Karl C K Kuban; Thomas Michael O'Shea; Nigel Paneth; Joseph Majzoub
Journal:  Acta Paediatr       Date:  2015-11-13       Impact factor: 2.299

7.  The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration.

Authors:  David M Kent; David van Klaveren; Jessica K Paulus; Ralph D'Agostino; Steve Goodman; Rodney Hayward; John P A Ioannidis; Bray Patrick-Lake; Sally Morton; Michael Pencina; Gowri Raman; Joseph S Ross; Harry P Selker; Ravi Varadhan; Andrew Vickers; John B Wong; Ewout W Steyerberg
Journal:  Ann Intern Med       Date:  2019-11-12       Impact factor: 25.391

8.  Dealing with heterogeneity of treatment effects: is the literature up to the challenge?

Authors:  Nicole B Gabler; Naihua Duan; Diana Liao; Joann G Elmore; Theodore G Ganiats; Richard L Kravitz
Journal:  Trials       Date:  2009-06-19       Impact factor: 2.279

9.  The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement.

Authors:  David M Kent; Jessica K Paulus; David van Klaveren; Ralph D'Agostino; Steve Goodman; Rodney Hayward; John P A Ioannidis; Bray Patrick-Lake; Sally Morton; Michael Pencina; Gowri Raman; Joseph S Ross; Harry P Selker; Ravi Varadhan; Andrew Vickers; John B Wong; Ewout W Steyerberg
Journal:  Ann Intern Med       Date:  2019-11-12       Impact factor: 25.391

10.  Sun exposure and malignant melanoma among susceptible individuals.

Authors:  N Dubin; M Moseson; B S Pasternack
Journal:  Environ Health Perspect       Date:  1989-05       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.